A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

Conditions: Myasthenia Gravis Interventions: Biological: efgartigimod Sponsors: argenx Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials